Immutep (IMMP) Non-Current Deferred Tax Liability (2014 - 2022)
Immutep's (IMMP) quarterly Non-Current Deferred Tax Liability came in at $748086.4 in Q2 2022, down 48.55% on a QoQ basis from $1.5 million in Q2 2019.
Immutep (IMMP) Non-Current Deferred Tax Liability (2014 - 2022) Analysis & Trends
Immutep (IMMP) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $748086.4 in Q2 2022.
- Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $748086.4 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $748086.4 (changed N/A YoY) and the FY2022 annual result came in at $748086.4, changed N/A from the prior year.
- Non-Current Deferred Tax Liability declined to $748086.4 in Q2 2022, from $1.5 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $2.1 million in Q2 2018 to a low of $748086.4 in Q2 2022.
- A 3-year average of $1.4 million and a median of $1.5 million in 2019 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2018 — Non-Current Deferred Tax Liability fell 2.91% — and 2019, when it slipped 29.71%.
- Tracing IMMP's Non-Current Deferred Tax Liability over 3 years: stood at $2.1 million in 2018, then slipped by 29.71% to $1.5 million in 2019, then sank by 48.55% to $748086.4 in 2022.
- The last three Non-Current Deferred Tax Liability figures came in at $748086.4 (Q2 2022), $1.5 million (Q2 2019), and $2.1 million (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 748,086.40 |
| Jun 30, 2022 | 748,086.40 |
| Jun 30, 2019 | 1.45 Mn |
| Jun 30, 2019 | 1.45 Mn |
| Jun 30, 2018 | 2.07 Mn |
| Jun 30, 2018 | 2.07 Mn |
| Jun 30, 2017 | 2.13 Mn |
| Jun 30, 2017 | 2.13 Mn |
| Jun 30, 2016 | 518,356.34 |
| Jun 30, 2016 | 518,356.34 |
| Jun 30, 2015 | 1.46 Mn |
| Jun 30, 2015 | 1.46 Mn |
| Dec 31, 2014 | 3.01 Bn |
| Dec 31, 2014 | 3.01 Bn |